Refractory Malignant Solid Neoplasm trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Refractory Malignant Solid Neoplasm trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
  NCT04851119 · Phase: Phase 1, Phase 2 · Ages: 12 Months to 30 Years · Sex: All (male and female) · District of Columbia: Washington D.C.